Published in J Bone Miner Res on July 01, 2008
DNA damage drives accelerated bone aging via an NF-κB-dependent mechanism. J Bone Miner Res (2013) 1.31
Concise review: the periosteum: tapping into a reservoir of clinically useful progenitor cells. Stem Cells Transl Med (2012) 1.22
The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem Biophys Res Commun (2010) 1.13
Stromal cell-derived factor-1β potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro. Tissue Eng Part A (2012) 1.02
Stromal cell-derived factor-1β mediates cell survival through enhancing autophagy in bone marrow-derived mesenchymal stem cells. PLoS One (2013) 0.98
Temperatures rising: brown fat and bone. Discov Med (2011) 0.95
Myostatin (GDF-8) inhibits chondrogenesis and chondrocyte proliferation in vitro by suppressing Sox-9 expression. Growth Factors (2011) 0.92
Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells. Exp Gerontol (2012) 0.91
Age-related marrow adipogenesis is linked to increased expression of RANKL. J Biol Chem (2014) 0.90
Age and skeletal sites affect BMP-2 responsiveness of human bone marrow stromal cells. Connect Tissue Res (2009) 0.87
Glucocorticoid-induced leucine zipper (GILZ) antagonizes TNF-α inhibition of mesenchymal stem cell osteogenic differentiation. PLoS One (2012) 0.84
miR-10a restores human mesenchymal stem cell differentiation by repressing KLF4. J Cell Physiol (2013) 0.82
Role of glucocorticoid-induced leucine zipper (GILZ) in bone acquisition. J Biol Chem (2014) 0.81
Impact of targeted PPARγ disruption on bone remodeling. Mol Cell Endocrinol (2015) 0.81
Single-Cell RNA-Seq of Bone Marrow-Derived Mesenchymal Stem Cells Reveals Unique Profiles of Lineage Priming. PLoS One (2015) 0.81
Oxidation of the aromatic amino acids tryptophan and tyrosine disrupts their anabolic effects on bone marrow mesenchymal stem cells. Mol Cell Endocrinol (2015) 0.80
Aromatic amino acid activation of signaling pathways in bone marrow mesenchymal stem cells depends on oxygen tension. PLoS One (2014) 0.80
The status of glucocorticoid-induced leucine zipper protein in the salivary glands in Sjögren's syndrome: predictive and prognostic potentials. EPMA J (2016) 0.78
Role of the Cytokine-like Hormone Leptin in Muscle-bone Crosstalk with Aging. J Bone Metab (2017) 0.78
Mesenchymal stem cell expression of SDF-1β synergizes with BMP-2 to augment cell-mediated healing of critical-sized mouse calvarial defects. J Tissue Eng Regen Med (2015) 0.78
Total body irradiation is permissive for mesenchymal stem cell-mediated new bone formation following local transplantation. Tissue Eng Part A (2014) 0.77
Caloric restriction and the adipokine leptin alter the SDF-1 signaling axis in bone marrow and in bone marrow derived mesenchymal stem cells. Mol Cell Endocrinol (2015) 0.77
Mesenchymal stem cell expression of stromal cell-derived factor-1β augments bone formation in a model of local regenerative therapy. J Orthop Res (2014) 0.76
Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response. Cell Mol Immunol (2015) 0.75
Effect of Mesenchymal Stem Cells and Platelet-Rich Plasma on the Bone Healing of Ovariectomized Rats. Stem Cells Int (2016) 0.75
Exercise affects biological characteristics of mesenchymal stromal cells derived from bone marrow and adipose tissue. Int Orthop (2017) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Marrow stromal cells as stem cells for nonhematopoietic tissues. Science (1997) 17.06
Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature (2005) 11.23
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A (1996) 8.53
Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev (2000) 6.42
Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem (1997) 6.30
Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve (1995) 3.84
Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem (1999) 3.75
Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci (1992) 3.69
Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res (1971) 3.58
Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab (2000) 3.42
Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res (1999) 3.05
Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res (2004) 2.34
Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res (2001) 2.04
Bone development and age-related bone loss in male C57BL/6J mice. Bone (2003) 2.02
Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells. Mol Pharmacol (1996) 1.90
Red and yellow marrow in the femur: age-related changes in appearance at MR imaging. Radiology (1990) 1.79
Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci (1992) 1.78
Age-related impairment of mesenchymal progenitor cell function. Aging Cell (2006) 1.66
Species differences in growth requirements for bone marrow stromal fibroblast colony formation In vitro. Calcif Tissue Int (1996) 1.59
Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res (1993) 1.49
Hematopoietic origin of fibroblasts/myofibroblasts: Its pathophysiologic implications. Blood (2006) 1.48
Factors required for bone marrow stromal fibroblast colony formation in vitro. Br J Haematol (1997) 1.45
Age-related loss of muscle mass and bone strength in mice is associated with a decline in physical activity and serum leptin. Bone (2006) 1.45
Age-related changes in osteogenic stem cells in mice. J Bone Miner Res (1996) 1.42
Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J Bone Miner Res (2003) 1.33
Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ). J Biol Chem (2007) 1.28
A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep (2003) 1.27
Influence of mature adipocytes on osteoblast proliferation in human primary cocultures. Bone (2000) 1.20
Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J Biol Chem (2002) 1.13
Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression. J Cell Biochem (2008) 1.06
Age-related bone loss. A hypothesis and initial assessment in mice. Clin Orthop Relat Res (1995) 1.01
Bone microarchitecture of the calcaneus and its changes in aging: a histomorphometric analysis of 60 human specimens. J Orthop Res (2006) 1.00
Promoting effects of serotonin on hematopoiesis: ex vivo expansion of cord blood CD34+ stem/progenitor cells, proliferation of bone marrow stromal cells, and antiapoptosis. Stem Cells (2007) 0.98
Comparison of fetal and adult marrow stromal cells in osteogenesis with and without glucocorticoids. Connect Tissue Res (2006) 0.92
Longitudinal analysis of mesenchymal progenitors and bone quality in the stem cell antigen-1-null osteoporotic mouse. J Bone Miner Res (2007) 0.91
Concentration of transforming growth factor beta in human bone tissue: relationship to age, menopause, bone turnover, and bone volume. J Bone Miner Res (1998) 0.90
Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women. Calcif Tissue Int (2000) 0.87
Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus. Cytokine Growth Factor Rev (1996) 0.85
Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions. Exp Gerontol (2000) 0.83
Age-related decline in bone mass measured by dual-energy X-ray absorptiometry and quantitative ultrasound in a population-based sample of both sexes: identification of useful ultrasound thresholds for osteoporosis screening. J Clin Densitom (2005) 0.80
Basic fibroblast growth factor corrects proliferative derangement of bone marrow stroma and CD34(+) population following allogeneic stem cell transplantation. Exp Hematol (2001) 0.78
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet (2005) 29.45
Subtypes of breast cancer show preferential site of relapse. Cancer Res (2008) 4.38
Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. Cancer Res (2006) 4.11
MicroRNA-mediated control of oligodendrocyte differentiation. Neuron (2010) 3.24
ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem (2007) 2.31
Fibroblast growth factor-2 and bone morphogenetic protein-2 have a synergistic stimulatory effect on bone formation in cell cultures from elderly mouse and human bone. J Gerontol A Biol Sci Med Sci (2013) 2.12
Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol (2010) 1.82
Tie2cre-induced inactivation of the miRNA-processing enzyme Dicer disrupts invariant NKT cell development. Proc Natl Acad Sci U S A (2009) 1.75
Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice. J Bone Miner Res (2011) 1.72
Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases. RNA Biol (2012) 1.64
Cultural consensus analysis as a tool for clinic improvements. J Gen Intern Med (2004) 1.52
Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine. J Bone Miner Res (2013) 1.52
microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am J Physiol Renal Physiol (2011) 1.50
Age-related loss of muscle mass and bone strength in mice is associated with a decline in physical activity and serum leptin. Bone (2006) 1.45
Type a botulinum toxin-induced antibody production: a murine model of antibody response. Aesthet Surg J (2009) 1.38
Avoiding wrong site surgery: a systematic review. Spine (Phila Pa 1976) (2010) 1.31
Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ). J Biol Chem (2007) 1.28
Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells. J Clin Endocrinol Metab (2012) 1.25
MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival. Mol Med (2010) 1.25
MicroRNA miR-150 is involved in Vα14 invariant NKT cell development and function. J Immunol (2012) 1.24
Effects of increased muscle mass on mouse sagittal suture morphology and mechanics. Anat Rec A Discov Mol Cell Evol Biol (2004) 1.22
Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weight. J Bone Miner Res (2008) 1.20
Identification of endogenous normalizers for serum microRNAs by microarray profiling: U6 small nuclear RNA is not a reliable normalizer. Hepatology (2012) 1.19
A qualitative study of resident learning in ambulatory clinic. The importance of exposure to 'breakdown' in settings that support effective response. Adv Health Sci Educ Theory Pract (2004) 1.19
Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume. Bone (2008) 1.17
Lower bone mass in prepubertal overweight children with prediabetes. J Bone Miner Res (2010) 1.17
Developing and validating a conceptual model of recurring problems in teaching clinic. Adv Health Sci Educ Theory Pract (2006) 1.15
SUMO wrestling with type 1 diabetes. J Mol Med (Berl) (2005) 1.13
The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem Biophys Res Commun (2010) 1.13
Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss. Biochem Biophys Res Commun (2005) 1.11
A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin. J Mol Diagn (2006) 1.08
Effects of glucose-dependent insulinotropic peptide on osteoclast function. Am J Physiol Endocrinol Metab (2006) 1.08
Force plate for measuring the ground reaction forces in small animal locomotion. J Biomech (2005) 1.07
Glucocorticoid-induced leucine zipper (GILZ) mediates glucocorticoid action and inhibits inflammatory cytokine-induced COX-2 expression. J Cell Biochem (2008) 1.06
Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with beta-cell function. J Clin Endocrinol Metab (2011) 1.06
Prognostic gene expression signatures can be measured in tissues collected in RNAlater preservative. J Mol Diagn (2006) 1.06
CCL4 protects from type 1 diabetes by altering islet beta-cell-targeted inflammatory responses. Diabetes (2007) 1.05
Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells. J Immunol (2006) 1.05
a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III. J Clin Endocrinol Metab (2013) 1.05
Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism. Diabetes (2010) 1.04
Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover. Bone (2005) 1.03
Stromal cell-derived factor-1β potentiates bone morphogenetic protein-2-stimulated osteoinduction of genetically engineered bone marrow-derived mesenchymal stem cells in vitro. Tissue Eng Part A (2012) 1.02
Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass. Bone (2007) 1.01
MicroRNAs and immune regulatory T cells. Int Immunopharmacol (2009) 1.01
Evaluation of clinical results, histological architecture, and collagen expression following treatment of mature burn scars with a fractional carbon dioxide laser. JAMA Dermatol (2013) 1.01
Multiple melanocortin receptors are expressed in bone cells. Bone (2005) 1.00
Stromal cell-derived factor-1β mediates cell survival through enhancing autophagy in bone marrow-derived mesenchymal stem cells. PLoS One (2013) 0.98
Patterns of correlation and covariation of anthropoid distal forelimb segments correspond to Hoxd expression territories. J Exp Zool B Mol Dev Evol (2008) 0.98
Loss of microRNAs in thymus perturbs invariant NKT cell development and function. Cell Mol Immunol (2010) 0.98
Restoration of regenerative osteoblastogenesis in aged mice: modulation of TNF. J Bone Miner Res (2010) 0.97
High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway. J Biol Chem (2003) 0.97
Green tea polyphenol induces caspase 14 in epidermal keratinocytes via MAPK pathways and reduces psoriasiform lesions in the flaky skin mouse model. Exp Dermatol (2007) 0.97
Effect of whole-body vibration on bone properties in aging mice. Bone (2010) 0.97
Multiple single nucleotide polymorphisms in the human urate transporter 1 (hURAT1) gene are associated with hyperuricaemia in Han Chinese. J Med Genet (2009) 0.96
Impact of glucose-dependent insulinotropic peptide on age-induced bone loss. J Bone Miner Res (2008) 0.96
BrdU-positive cells in the neonatal mouse hippocampus following hypoxic-ischemic brain injury. BMC Neurosci (2005) 0.95
Green tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14. J Pharmacol Exp Ther (2004) 0.94
Testing the exportability of a tool for detecting operational problems in VA teaching clinics. J Gen Intern Med (2005) 0.94
MicroRNA genes. Ann N Y Acad Sci (2008) 0.93
Insulin-like growth factor (IGF)-I/IGF-binding protein-3 complex: therapeutic efficacy and mechanism of protection against type 1 diabetes. Endocrinology (2003) 0.93
Lack of microRNA miR-150 reduces the capacity of epidermal Langerhans cell cross-presentation. Exp Dermatol (2012) 0.93
Myostatin (GDF-8) inhibits chondrogenesis and chondrocyte proliferation in vitro by suppressing Sox-9 expression. Growth Factors (2011) 0.92
Inexpensive self-retaining retractor for minor surgical procedures. Ann Plast Surg (2003) 0.92
Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci. Diabetes (2002) 0.91
Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells. Exp Gerontol (2012) 0.91
Effects of glucose-dependent insulinotropic peptide on behavior. Peptides (2006) 0.91
Absence of functional leptin receptor isoforms in the POUND (Lepr(db/lb)) mouse is associated with muscle atrophy and altered myoblast proliferation and differentiation. PLoS One (2013) 0.90
Dendritic cell-epithelium interplay is a determinant factor for corneal epithelial wound repair. Am J Pathol (2011) 0.90
Fractal analysis of the PDL-bone interface and implications for orthodontic tooth movement. Am J Orthod Dentofacial Orthop (2005) 0.90
Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice. Anat Rec A Discov Mol Cell Evol Biol (2005) 0.90
Clinical and molecular effects on mature burn scars after treatment with a fractional CO(2) laser. Lasers Surg Med (2012) 0.90
Effects of subcutaneous leptin injections on hypothalamic gene profiles in lean and ob/ob mice. Obesity (Silver Spring) (2007) 0.90
A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength. Exp Gerontol (2013) 0.89
Mohs surgical treatment of a granular cell tumor on the toe of a child. Pediatr Dermatol (2007) 0.89
Deficient activation and resistance to activation-induced apoptosis of CD8+ T cells is associated with defective peripheral tolerance in nonobese diabetic mice. Clin Immunol (2003) 0.89
A mechanism-based in vitro anticancer drug screening approach for phenolic phytochemicals. Assay Drug Dev Technol (2003) 0.89
Sodium-dependent vitamin C transporter SVCT2: expression and function in bone marrow stromal cells and in osteogenesis. Stem Cell Res (2012) 0.88
Role of p21WAF1 in green tea polyphenol-induced growth arrest and apoptosis of oral carcinoma cells. Anticancer Res (2005) 0.88
Green tea polyphenols reduce autoimmune symptoms in a murine model for human Sjogren's syndrome and protect human salivary acinar cells from TNF-alpha-induced cytotoxicity. Autoimmunity (2007) 0.88
NALP3 inflammasome functional polymorphisms and gout susceptibility. Cell Cycle (2009) 0.88
Ectopic osteogenesis and chondrogenesis of bone marrow stromal stem cells in alginate system. Cell Biol Int (2007) 0.87
The regulation and function of microRNAs in kidney diseases. IUBMB Life (2013) 0.87
Inhibition of endogenous dentin matrix metalloproteinases by ethylenediaminetetraacetic acid. J Endod (2011) 0.87
Low-dose bone morphogenetic protein-2/stromal cell-derived factor-1β cotherapy induces bone regeneration in critical-size rat calvarial defects. Tissue Eng Part A (2014) 0.87